Philips acquires teleradiology services provider Direct Radiology
Philips has expanded its radiology portfolio with the acquisition of Idaho-based teleradiology services provider Direct Radiology to enhance access to precision diagnoses.
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn MorePhilips has expanded its radiology portfolio with the acquisition of Idaho-based teleradiology services provider Direct Radiology to enhance access to precision diagnoses.
Salt Lake City, Utah-based X-ray tubes and image processing solutions-maker Varex Imaging has agreed to acquire at least 90% of stock of Direct Conversion.
UK-based cancer diagnostics firm Oncimmune has acquired Protagen Diagnostics, a company focused the development of diagnostic tools to support therapeutic development and facilitate improved treatment strategies in the areas of immuno-oncology and autoimmune disease.
Mobidiag, a commercial stage molecular diagnostics company addressing the spread of antimicrobial resistance, has signed multiple exclusive agreements with international partners for the distribution of its Amplidiag and Novodiag products in Europe and the Middle East.
Vance Street Capital LLC, a Los Angeles-based private equity firm, announced the acquisition of Applied Plastics (“Applied”), an advanced coatings provider to the medical end markets.
Marubeni has purchased a stake in AI deep-learning backed image diagnosis system developer, Enlitic.
Francis Medical, a company engaged in the development of developing urological cancer treatments, has raised $18m Series A funding for cancer ablation technology using water vapor.
LGC, which owned by funds affiliated with global investment firm KKR. has acquired SeraCare Life Sciences to strengthen its position in clinical quality control tools.
Boston Scientific, an American manufacturer of medical devices used in interventional medical specialties, has announced a recommended offer to acquire the UK-based healthcare firm BTG for $4.2bn.
Illumina, a sequencing and array-based solutions provider for genetic research, has agreed to acquire sequencing systems provider Pacific Biosciences for $1.2bn in an all-cash transaction.